Mein Warenkorb

HLA-A*0201 & B2M & p53 (HMTEVVRRC)

HLA-A*0201 & B2M & p53 (HMTEVVRRC) Produktliste

  • Attribut

    Protein (2)

  • Produktbibliothek

    Online (2)

  • Spezies

    Human (2)

  • Etikett

    His Tag & Avi Tag (1)His Tag (1)

  • Marker

    Biotin-labeled (1)Unconjugated (1)

ProduktnummerSpeziesExpressionssystemProduktbeschreibungProteinstrukturReinheitEigenschaftenVorbestellen/Bestellen
HL3-H82E6
Human
HEK293
Biotinylated Human HLA-A*02:01&B2M&p53 (HMTEVVRRC) Complex Protein (Monomer, MALS verified) In den Warenkorb legen
HLP-H82Ee
Human
HEK293
Human HLA-A*02:01&B2M&p53 (HMTEVVRRC) Tetramer Protein (MALS verified) In den Warenkorb legen
Gesamtmenge2
  • 1

HLA-A*0201 & B2M & p53 (HMTEVVRRC) Molekülhintergrund

TP53 has been recognized as a tumor suppressor. 50% of cancers carry a TP53 mutation while many others affect other pathway components. High-copy numbers of WT p53 peptide-MHC class I complexes were detected on tumor cells as compared to low copies on normal cells. The Human HLA-A*0201 p53 (HMTEVVRRC) complex protein is a complex of HLA-A*0201 of the MHC Class I, B2M, and HMTEVVRRC peptide of the p53.

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
VT-1021VT-1021Phase 1 ClinicalVigeo Therapeutics IncSolid tumours
Details
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns